BetaSync MedTech Inc.

About BetaSync

BetaSync MedTech Inc. is a medical technology startup developing an intelligent device to assist with insulin injections. The device checks the injection area before each injection using integrated sensors, analyzes factors such as pressure response and surface texture, and processes the data locally on an internal AI chip—without internet connection and without data transmission. The system recommends better injection sites, avoids stressed tissue, and supports a clean rotation of injection sites. Analytics and reports help patients, caregivers, and clinicians monitor and adjust the rotation routine. For clinics and large programs, the company offers an Enterprise solution with multi-patient management, data integration, as well as training and support. The founder and CEO is Abhishek Bohare, an experimental nuclear and particle physicist who worked at CERN. The company was awarded the Engineers and Scientists in Business Fellowship (ESBF) and aims, according to its own statement, to protect the long-term skin health of diabetes patients.

Processes

Intelligent injection guidance (sensor-based inspection of the injection area), Local AI analysis on integrated chip (offline), Injection site rotation tracking and monitoring, Analytics and reports for patients, caregivers, and clinicians, Multi-patient management for clinics (Enterprise), Data integration and training/support (Enterprise)

Industries

Medical Technology, Diabetes Care, Healthcare

1. 01

   Sensor-based inspection of the injection area

2. 02

   Local AI analysis on integrated chip (offline)

3. 03

   Rotation tracking and monitoring

4. 04

   Analytics and reports

5. 05

   Enterprise services (data integration, training, support)

Product

Inside the production

History

1. 2026

   BetaSync MedTech Inc. was awarded the Engineers and Scientists in Business Fellowship (ESBF) (announced on 05.01.2026).